Zelira Therapeutics (ASX:ZLD) Inventories, Finished Goods: A$0.02 Mil (As of Jun. 2025)


What is Zelira Therapeutics Inventories, Finished Goods?

Zelira Therapeutics ASX:ZLD Inventories, Finished Goods is A$0.02 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

Zelira Therapeutics's quarterly finished goods declined from Jun. 2024 (A$0.05 Mil) to Dec. 2024 (A$0.00 Mil) but then increased from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$0.02 Mil).

Zelira Therapeutics's annual finished goods declined from Jun. 2023 (A$0.38 Mil) to Jun. 2024 (A$0.05 Mil) and declined from Jun. 2024 (A$0.05 Mil) to Jun. 2025 (A$0.02 Mil).

Zelira Therapeutics Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Zelira Therapeutics's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zelira Therapeutics Inventories, Finished Goods Chart

Zelira Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.76 0.38 0.05 0.02

Zelira Therapeutics Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.00 0.05 0.00 0.02

Zelira Therapeutics Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of A$0.02 Mil mean?
Zelira Therapeutics (ASX:ZLD) has a Inventories, Finished Goods of A$0.02 Mil as of Jun. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Zelira Therapeutics and its competitors.
Is Zelira Therapeutics' Inventories, Finished Goods too high?
Zelira Therapeutics' current Inventories, Finished Goods is A$0.02 Mil.
How does Zelira Therapeutics' Inventories, Finished Goods compare to MTNB and SXTP?
Zelira Therapeutics' Inventories, Finished Goods of A$0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Zelira Therapeutics and its competitors. Zelira Therapeutics's current Inventories, Finished Goods is A$0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zelira Therapeutics stock overvalued right now?
Zelira Therapeutics (ASX:ZLD) has a current Inventories, Finished Goods of A$0.02 Mil. The stock's GF Value™ is A$0.12, compared to a current price of A$0.50 — trading 316.7% above its estimated fair value. The current Inventories, Finished Goods is A$0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Zelira Therapeutics (ASX:ZLD), the current Inventories, Finished Goods is A$0.02 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zelira Therapeutics Business Description

Other Exchanges ZLDAF:USA
Address 101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. The company is organised into two operating segments based on geographic location of operations: Australia and United States of America.